spacer
spacer

PDBsum entry 1uw3

Go to PDB code: 
protein ligands links
Membrane protein PDB id
1uw3

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
106 a.a. *
Ligands
GSH
PO4
Waters ×71
* Residue conservation analysis
PDB id:
1uw3
Name: Membrane protein
Title: The crystal structure of the globular domain of sheep prion protein
Structure: Prion protein. Chain: a. Fragment: residues 128-233. Synonym: sheep prion protein
Source: Ovis aries. Sheep. Organism_taxid: 9940
Biol. unit: Dimer (from PDB file)
Resolution:
2.05Å     R-factor:   0.227     R-free:   0.330
Authors: L.F.Haire,S.M.Whyte,N.Vasisht,A.C.Gill,C.Verma,E.J.Dodson,G.G.Dodson, P.M.Bayley
Key ref:
L.F.Haire et al. (2004). The crystal structure of the globular domain of sheep prion protein. J Mol Biol, 336, 1175-1183. PubMed id: 15037077 DOI: 10.1016/j.jmb.2003.12.059
Date:
29-Jan-04     Release date:   25-Mar-04    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P23907  (PRIO_SHEEP) -  Major prion protein from Ovis aries
Seq:
Struc:
256 a.a.
106 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 3 residue positions (black crosses)

 

 
DOI no: 10.1016/j.jmb.2003.12.059 J Mol Biol 336:1175-1183 (2004)
PubMed id: 15037077  
 
 
The crystal structure of the globular domain of sheep prion protein.
L.F.Haire, S.M.Whyte, N.Vasisht, A.C.Gill, C.Verma, E.J.Dodson, G.G.Dodson, P.M.Bayley.
 
  ABSTRACT  
 
The prion protein PrP is a naturally occurring polypeptide that becomes transformed from a normal conformation to that of an aggregated form, characteristic of pathological states in fatal transmissible spongiform conditions such as Creutzfeld-Jacob Disease and Bovine Spongiform Encephalopathy. We report the crystal structure, at 2 A resolution, of residues 123-230 of the C-terminal globular domain of the ARQ allele of sheep prion protein (PrP). The asymmetric unit contains a single molecule whose secondary structure and overall organisation correspond to those structures of PrPs from various mammalian species determined by NMR. The globular domain shows a close association of helix-1, the C-terminal portion of helix-2 and the N-terminal portion of helix-3, bounded by the intramolecular disulphide bond, 179-214. The loop 164-177, between beta2 and helix-2 is relatively well structured compared to the human PrP NMR structure. Analysis of the sheep PrP structure identifies two possible loci for the initiation of beta-sheet mediated polymerisation. One of these comprises the beta-strand, residues 129-131 that forms an intra-molecular beta-sheet with residues 161-163. This strand is involved in lattice contacts about a crystal dyad to generate a four-stranded intermolecular beta-sheet between neighbouring molecules. The second locus involves the region 188-204, which modelling suggests is able to undergo a partial alpha-->beta switch within the monomer. These loci provide sites within the PrPc monomer that could readily give rise to early intermediate species on the pathway to the formation of aggregated PrPSc containing additional intermolecular beta-structure.
 
  Selected figure(s)  
 
Figure 2.
Figure 2. A, Portion of a CNS all omit map covering the vicinity of the phosphate ion linking the segment of the polypeptide at the immediate N terminus of helix-1 with the middle section of helix-3. (Liganding to Glu146 is not shown for clarity, see the text.) B, Schematic representation of the sheep PrP molecule. The helices, labelled H1-H3, are shown in blue, and the short segments of anti-parallel b-sheet are shown in red. C, Schematic representation of the helix-swapped dimer structure of the human prion protein.[6.] The bottom half of the dimer is in the same orientation as the sheep PrP shown in B and similarly coloured, but with H3 in light blue. The dyad-related monomer is at the top and its b-strands are coloured in green. The helices for the dyad-related molecule are distinguished by a prime. The exchange of H3 and H3' is accompanied by the formation of an additional segment of anti-parallel b-sheet, coloured in red and green (Figure drawn with Spock).
Figure 3.
Figure 3. Comparison of the crystal structure of the globular domain of the ARQ allele of sheep PrP (blue) and the NMR structure of human PrP (yellow: 1hjm.pdb): least-squares superimposition of common residues, with an rms DIFFERENCE=1.73 Å for 100 C^a atoms. In addition to the three helices, the intramolecular b-sheet (arrows, b1:129-131; b2:161-163) is shown in red for sheep PrP, and grey for human PrP. The YYR epitope is at 162-164. The loop 164-174 between b2 and H2, is shown in green for sheep PrP. The three polymorphic residues of sheep (A133,R151,Q168), are shown in magenta (Figure drawn with Spock).
 
  The above figures are reprinted by permission from Elsevier: J Mol Biol (2004, 336, 1175-1183) copyright 2004.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
20337594 C.A.Tabrett, C.F.Harrison, B.Schmidt, S.A.Bellingham, T.Hardy, Y.H.Sanejouand, A.F.Hill, and P.J.Hogg (2010).
Changing the solvent accessibility of the prion protein disulfide bond markedly influences its trafficking and effect on cell function.
  Biochem J, 428, 169-182.  
20685658 M.I.Apostol, M.R.Sawaya, D.Cascio, and D.Eisenberg (2010).
Crystallographic studies of prion protein (PrP) segments suggest how structural changes encoded by polymorphism at residue 129 modulate susceptibility to human prion disease.
  J Biol Chem, 285, 29671-29675.
PDB codes: 3nhc 3nhd
21041683 M.Q.Khan, B.Sweeting, V.K.Mulligan, P.E.Arslan, N.R.Cashman, E.F.Pai, and A.Chakrabartty (2010).
Prion disease susceptibility is affected by beta-structure folding propensity and local side-chain interactions in PrP.
  Proc Natl Acad Sci U S A, 107, 19808-19813.
PDB code: 3o79
19927125 S.Lee, L.Antony, R.Hartmann, K.J.Knaus, K.Surewicz, W.K.Surewicz, and V.C.Yee (2010).
Conformational diversity in prion protein variants influences intermolecular beta-sheet formation.
  EMBO J, 29, 251-262.
PDB codes: 3haf 3hak 3heq 3her 3hes 3hj5 3hjx
19283723 A.Nazabal, S.Hornemann, A.Aguzzi, and R.Zenobi (2009).
Hydrogen/deuterium exchange mass spectrometry identifies two highly protected regions in recombinant full-length prion protein amyloid fibrils.
  J Mass Spectrom, 44, 965-977.  
19538144 E.D.Walter, D.J.Stevens, A.R.Spevacek, M.P.Visconte, A.Dei Rossi, and G.L.Millhauser (2009).
Copper binding extrinsic to the octarepeat region in the prion protein.
  Curr Protein Pept Sci, 10, 529-535.  
20052907 F.Cui, K.Mukhopadhyay, W.B.Young, R.L.Jernigan, and Z.Wu (2009).
Refinement of under-determined loops of Human Prion Protein by database-derived distance constraints.
  Int J Data Min Bioinform, 3, 454-468.  
19035579 L.Ronga, P.Palladino, R.Ragone, E.Benedetti, and F.Rossi (2009).
A thermodynamic approach to the conformational preferences of the 180-195 segment derived from the human prion protein alpha2-helix.
  J Pept Sci, 15, 30-35.  
18813919 O.Polyakova, D.Dear, I.Stern, S.Martin, E.Hirst, S.Bawumia, A.Nash, G.Dodson, I.Bronstein, and P.M.Bayley (2009).
Proteolysis of prion protein by cathepsin S generates a soluble beta-structured intermediate oligomeric form, with potential implications for neurotoxic mechanisms.
  Eur Biophys J, 38, 209-218.  
19157856 R.A.Moore, L.M.Taubner, and S.A.Priola (2009).
Prion protein misfolding and disease.
  Curr Opin Struct Biol, 19, 14-22.  
19204296 S.V.Antonyuk, C.R.Trevitt, R.W.Strange, G.S.Jackson, D.Sangar, M.Batchelor, S.Cooper, C.Fraser, S.Jones, T.Georgiou, A.Khalili-Shirazi, A.R.Clarke, S.S.Hasnain, and J.Collinge (2009).
Crystal structure of human prion protein bound to a therapeutic antibody.
  Proc Natl Acad Sci U S A, 106, 2554-2558.
PDB codes: 2w9d 2w9e
18563793 L.Ronga, P.Palladino, G.Saviano, T.Tancredi, E.Benedetti, R.Ragone, and F.Rossi (2008).
Structural characterization of a neurotoxic threonine-rich peptide corresponding to the human prion protein alpha 2-helical 180-195 segment, and comparison with full-length alpha 2-helix-derived peptides.
  J Pept Sci, 14, 1096-1102.  
17876822 M.C.Colombo, J.Vandevondele, S.Van Doorslaer, A.Laio, L.Guidoni, and U.Rothlisberger (2008).
Copper binding sites in the C-terminal domain of mouse prion protein: A hybrid (QM/MM) molecular dynamics study.
  Proteins, 70, 1084-1098.  
18533092 S.Noinville, J.F.Chich, and H.Rezaei (2008).
Misfolding of the prion protein: linking biophysical and biological approaches.
  Vet Res, 39, 48.  
18248567 V.Gayrard, N.Picard-Hagen, C.Viguié, E.Jeunesse, G.Tabouret, H.Rezaei, and P.L.Toutain (2008).
Blood clearance of the prion protein introduced by intravenous route in sheep is influenced by host genetic and physiopathologic factors.
  Transfusion, 48, 609-619.  
17483173 A.De Simone, A.Zagari, and P.Derreumaux (2007).
Structural and hydration properties of the partially unfolded states of the prion protein.
  Biophys J, 93, 1284-1292.  
  19164911 A.Pastore, and A.Zagari (2007).
A structural overview of the vertebrate prion proteins.
  Prion, 1, 185-197.  
17397138 C.W.Lennon, H.D.Cox, S.P.Hennelly, S.J.Chelmo, and M.A.McGuirl (2007).
Probing structural differences in prion protein isoforms by tyrosine nitration.
  Biochemistry, 46, 4850-4860.  
17076634 G.L.Millhauser (2007).
Copper and the prion protein: methods, structures, function, and disease.
  Annu Rev Phys Chem, 58, 299-320.  
17288547 I.V.Baskakov (2007).
The reconstitution of mammalian prion infectivity de novo.
  FEBS J, 274, 576-587.  
17152078 L.Ronga, E.Langella, P.Palladino, D.Marasco, B.Tizzano, M.Saviano, C.Pedone, R.Improta, and M.Ruvo (2007).
Does tetracycline bind helix 2 of prion? An integrated spectroscopical and computational study of the interaction between the antibiotic and alpha helix 2 human prion protein fragments.
  Proteins, 66, 707-715.  
17244617 Y.Sun, L.Breydo, N.Makarava, Q.Yang, O.V.Bocharova, and I.V.Baskakov (2007).
Site-specific conformational studies of prion protein (PrP) amyloid fibrils revealed two cooperative folding domains within amyloid structure.
  J Biol Chem, 282, 9090-9097.  
16972036 C.D.Wu, W.Y.Pang, and D.M.Zhao (2006).
Comparative analysis of the prion protein gene sequences in African lion.
  Virus Genes, 33, 213-214.  
16639746 E.Langella, R.Improta, O.Crescenzi, and V.Barone (2006).
Assessing the acid-base and conformational properties of histidine residues in human prion protein (125-228) by means of pK(a) calculations and molecular dynamics simulations.
  Proteins, 64, 167-177.  
17062011 L.Ronga, B.Tizzano, P.Palladino, R.Ragone, E.Urso, M.Maffia, M.Ruvo, E.Benedetti, and F.Rossi (2006).
The prion protein: Structural features and related toxic peptides.
  Chem Biol Drug Des, 68, 139-147.  
17131298 L.Ronga, P.Palladino, B.Tizzano, D.Marasco, E.Benedetti, R.Ragone, and F.Rossi (2006).
Effect of salts on the structural behavior of hPrP alpha2-helix-derived analogues: the counterion perspective.
  J Pept Sci, 12, 790-795.  
16519692 M.R.Hicks, A.C.Gill, I.K.Bath, A.K.Rullay, I.D.Sylvester, D.H.Crout, and T.J.Pinheiro (2006).
Synthesis and structural characterization of a mimetic membrane-anchored prion protein.
  FEBS J, 273, 1285-1299.  
17111435 S.Petrakis, and T.Sklaviadis (2006).
Identification of proteins with high affinity for refolded and native PrPC.
  Proteomics, 6, 6476-6484.  
15894615 A.De Simone, G.G.Dodson, C.S.Verma, A.Zagari, and F.Fraternali (2005).
Prion and water: tight and dynamical hydration sites have a key role in structural stability.
  Proc Natl Acad Sci U S A, 102, 7535-7540.  
15688445 B.Tizzano, P.Palladino, A.De Capua, D.Marasco, F.Rossi, E.Benedetti, C.Pedone, R.Ragone, and M.Ruvo (2005).
The human prion protein alpha2 helix: a thermodynamic study of its conformational preferences.
  Proteins, 59, 72-79.  
15647367 D.A.Lysek, C.Schorn, L.G.Nivon, V.Esteve-Moya, B.Christen, L.Calzolai, C.von Schroetter, F.Fiorito, T.Herrmann, P.Güntert, and K.Wüthrich (2005).
Prion protein NMR structures of cats, dogs, pigs, and sheep.
  Proc Natl Acad Sci U S A, 102, 640-645.
PDB codes: 1xyj 1xyk 1xyq 1xyu 1y2s
15647366 L.Calzolai, D.A.Lysek, D.R.Pérez, P.Güntert, and K.Wüthrich (2005).
Prion protein NMR structures of chickens, turtles, and frogs.
  Proc Natl Acad Sci U S A, 102, 651-655.
PDB codes: 1u3m 1u5l 1xu0
15684434 L.Redecke, W.Meyer-Klaucke, M.Koker, J.Clos, D.Georgieva, N.Genov, H.Echner, H.Kalbacher, M.Perbandt, R.Bredehorst, W.Voelter, and C.Betzel (2005).
Comparative analysis of the human and chicken prion protein copper binding regions at pH 6.5.
  J Biol Chem, 280, 13987-13992.  
15802644 O.V.Bocharova, L.Breydo, V.V.Salnikov, A.C.Gill, and I.V.Baskakov (2005).
Synthetic prions generated in vitro are similar to a newly identified subpopulation of PrPSc from sporadic Creutzfeldt-Jakob Disease.
  Protein Sci, 14, 1222-1232.  
16252284 R.Bujdoso, D.F.Burke, and A.M.Thackray (2005).
Structural differences between allelic variants of the ovine prion protein revealed by molecular dynamics simulations.
  Proteins, 61, 840-849.  
15377536 E.Langella, R.Improta, and V.Barone (2004).
Checking the pH-induced conformational transition of prion protein by molecular dynamics simulations: effect of protonation of histidine residues.
  Biophys J, 87, 3623-3632.  
15240887 F.Eghiaian, J.Grosclaude, S.Lesceu, P.Debey, B.Doublet, E.Tréguer, H.Rezaei, and M.Knossow (2004).
Insight into the PrPC-->PrPSc conversion from the structures of antibody-bound ovine prion scrapie-susceptibility variants.
  Proc Natl Acad Sci U S A, 101, 10254-10259.
PDB codes: 1tpx 1tqb 1tqc
15123682 L.L.Hosszu, G.S.Jackson, C.R.Trevitt, S.Jones, M.Batchelor, D.Bhelt, K.Prodromidou, A.R.Clarke, J.P.Waltho, and J.Collinge (2004).
The residue 129 polymorphism in human prion protein does not confer susceptibility to Creutzfeldt-Jakob disease by altering the structure or global stability of PrPC.
  J Biol Chem, 279, 28515-28521.  
15494440 R.I.Dima, and D.Thirumalai (2004).
Probing the instabilities in the dynamics of helical fragments from mouse PrPC.
  Proc Natl Acad Sci U S A, 101, 15335-15340.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.

 

spacer

spacer